These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension. Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268 [TBL] [Abstract][Full Text] [Related]
5. [Endogenous digoxin-like factor in myocardial infarction]. Bagrov AI; Kuznetsova EA; Fedorova OV Klin Med (Mosk); 1996; 74(4):15-7. PubMed ID: 8999142 [TBL] [Abstract][Full Text] [Related]
6. Effects of head down tilt on hemodynamics, fluid volumes, and plasma Na-K pump inhibitor in rats. Pamnani MB; Mo Z; Chen S; Bryant HJ; White RJ; Haddy FJ Aviat Space Environ Med; 1996 Oct; 67(10):928-34. PubMed ID: 9025814 [TBL] [Abstract][Full Text] [Related]
7. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients. Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459 [TBL] [Abstract][Full Text] [Related]
8. The reactivity of peripheral vessels of normo- and hypertensives. Haustein KO; Winkler U; Dück K; Richard F Int J Clin Pharmacol Ther Toxicol; 1992 Jun; 30(6):214-9. PubMed ID: 1319413 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of ouabain-insensitive red blood cell cation transport in uremic patients. Boero R; Quarello F; Guarena C; Piccoli G Boll Soc Ital Biol Sper; 1985 Feb; 61(2):243-8. PubMed ID: 3994843 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of active sodium and potassium transport in erythrocytes in children with different stages of symptomatic uremia. Sigström L Acta Paediatr Scand; 1981; 70(3):361-8. PubMed ID: 6454327 [TBL] [Abstract][Full Text] [Related]
13. [Changes in the activity of Na+ K+ ATPase in erythrocytes and immunoreactive plasma digoxin-like substances in chronic renal insufficiency: their relation to blood pressure levels]. Widimský J; Horký K; Lachmanová J; Dvoráková J Vnitr Lek; 1988 Sep; 34(9):843-50. PubMed ID: 2849244 [No Abstract] [Full Text] [Related]
15. Inhibition of erythrocyte Na,K-ATPase activity during anticipatory hypoventilation in micropigs. Fedorova OV; French AW; Anderson DE Am J Hypertens; 1996 Nov; 9(11):1126-31. PubMed ID: 8931839 [TBL] [Abstract][Full Text] [Related]
16. Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K]ATPase inhibitor. Graves SW; Glatter KA; Lazarus JM; Williams GH; Hollenberg NK J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S54-7. PubMed ID: 7508029 [TBL] [Abstract][Full Text] [Related]
17. Endogenous digoxin-like immunoreactivity and erythrocyte sodium transport in uraemic patients undergoing dialysis. Bosch RJ; Hernando N; Casado S; Lopez-Novoa JM Clin Sci (Lond); 1989 Feb; 76(2):157-63. PubMed ID: 2538291 [TBL] [Abstract][Full Text] [Related]
18. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane]. Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987 [TBL] [Abstract][Full Text] [Related]
19. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Alhamdani MS Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350 [TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risk markers in hemodialysis]. Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]